We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
-1.29%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$3.39B
AUM Growth
+$526M
(+18%)
Cap. Flow
+$586M
Cap. Flow
% of AUM
17.28%
Top 10 Holdings %
Top 10 Hldgs %
16.92%
Holding
1,543
New
205
Increased
822
Reduced
368
Closed
82
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$101M |
| 2 |
BCS.PRD.CL
Barclays Bank Plc
BCS.PRD.CL
|
+$45.8M |
| 3 |
Fidelity MSCI Consumer Staples Index ETF
FSTA
|
+$34.4M |
| 4 |
First Trust Large Cap Core AlphaDEX Fund
FEX
|
+$21.1M |
| 5 |
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
|
+$17.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 3000 ETF
IWV
|
+$20M |
| 2 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$14.1M |
| 3 |
Vanguard Morningstar Value ETF
VTV
|
+$13.5M |
| 4 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$11.6M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$8.52M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 5.38% |
| 2 | Financials | 4.91% |
| 3 | Technology | 4.68% |
| 4 | Healthcare | 4.32% |
| 5 | Industrials | 3.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Invesco Dorsey Wright Momentum ETF
PDP
$1.49B
| $3.79M | 0.11% |
96,400
-14,244
| -13% | -$561K |
|
177
First Trust Value Line Dividend Fund
FVD
$8.35B
| $3.78M | 0.11% |
168,296
+2,446
| +1% | +$55.5K |
|
178
US Bancorp
USB
$100B
| $3.75M | 0.11% |
89,645
+8,204
| +10% | +$347K |
|
179
SLB Ltd
SLB
$78.9B
| $3.59M | 0.11% |
35,289
+6,829
| +24% | +$745K |
|
180
Under Armour
UAA
$2.5B
| $3.58M | 0.11% |
103,504
+23,124
| +29% | +$771K |
|
181
American Electric Power
AEP
$66.9B
| $3.57M | 0.11% |
68,292
+3,915
| +6% | +$207K |
|
182
iShares Russell Mid-Cap Growth ETF
IWP
$20.7B
| $3.55M | 0.1% |
80,446
+3,904
| +5% | +$174K |
|
183
Medtronic
MDT
$114B
| $3.55M | 0.1% |
57,317
+2,394
| +4% | +$152K |
|
184
Norfolk Southern
NSC
$75B
| $3.55M | 0.1% |
31,790
+3,323
| +12% | +$352K |
|
185
Amazon
AMZN
$3T
| $3.52M | 0.1% |
218,640
+40,480
| +23% | +$673K |
|
186
Marvell Technology
MRVL
$187B
| $3.47M | 0.1% |
257,520
+11,256
| +5% | +$155K |
|
187
Oracle
ORCL
$435B
| $3.47M | 0.1% |
90,600
+4,382
| +5% | +$177K |
|
188
iShares Core MSCI EAFE ETF
IEFA
$195B
| $3.46M | 0.1% |
59,431
+25,473
| +75% | +$1.55M |
|
189
NYLI Hedge Multi-Strategy Tracker ETF
QAI
$1.02B
| $3.46M | 0.1% |
116,664
+8,741
| +8% | +$261K |
|
190
ROBO Global Robotics & Automation Index ETF
ROBO
$2.09B
| $3.45M | 0.1% |
+131,366
| New | +$3.56M |
|
191
Opko Health
OPK
$1.04B
| $3.45M | 0.1% |
405,272
+374,700
| +1,226% | +$3.29M |
|
192
BlackRock Enhanced Captial and Income Fund
CII
$1.02B
| $3.43M | 0.1% |
231,031
-1,322
| -0.6% | -$19.8K |
|
193
Phillips 66
PSX
$86B
| $3.43M | 0.1% |
42,135
+3,912
| +10% | +$326K |
|
|
VGI
194
Virtus Global Multi-Sector Income Fund
VGI
$83.5M
| $3.38M | 0.1% |
+197,649
| New | +$3.47M |
|
195
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.81B
| $3.33M | 0.1% |
36,234
+20,638
| +132% | +$1.79M |
|
196
Plains All American Pipeline
PAA
$16.4B
| $3.32M | 0.1% |
56,399
+1,708
| +3% | +$100K |
|
197
Colgate-Palmolive
CL
$74.3B
| $3.31M | 0.1% |
50,701
-6,114
| -11% | -$403K |
|
|
198
iShares Russell 3000 ETF
IWV
$20.4B
| $3.3M | 0.1% |
28,286
-169,919
| -86% | -$20M |
|
199
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.39B
| $3.29M | 0.1% |
115,722
+9,406
| +9% | +$273K |
|
200
CVS Health
CVS
$122B
| $3.28M | 0.1% |
41,249
+2,519
| +7% | +$199K |
|
Similar funds
LP
TI
Cambridge Investment Research Advisors's Q3 2014 Portfolio in Review
As of Q3 2014, Cambridge Investment Research Advisors held 1,543 positions worth $3.39B, up 18% from $2.87B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Cambridge Investment Research Advisors deployed $586M of net new capital in Q3 2014, opening 205 new positions and adding to 822 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 556,997 shares worth $101M.
By sector, the portfolio is most concentrated in Energy at 5.4% of assets, down from 6.5% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was iShares Russell 3000 ETF, an estimated $20M trimmed.
- Cambridge Investment Research Advisors's largest Q3 2014 buy was Vanguard S&P 500 ETF: 556,997 shares worth $101M.
- Cambridge Investment Research Advisors added most to Barclays Bank Plc in Q3 2014, an estimated $45.8M increase.
- Cambridge Investment Research Advisors's biggest Q3 2014 reduction was iShares Russell 3000 ETF, cutting an estimated $20M.
- Cambridge Investment Research Advisors fully exited iShares MSCI Taiwan ETF in Q3 2014, selling an estimated $1.83M.
- Cambridge Investment Research Advisors's ten largest holdings make up 17% of its $3.39B portfolio in Q3 2014.
- Cambridge Investment Research Advisors opened 205 new positions and closed 82 in Q3 2014.
- Cambridge Investment Research Advisors's portfolio value rose 18% quarter-over-quarter to $3.39B.
Based on Cambridge Investment Research Advisors's 13F filing for Q3 2014, filed 5 Nov 2014.